Attached files

file filename
8-K - FORM 8-K - DENDREON CORPd895601d8k.htm

Exhibit 99.1

 

THE UNITED STATES BANKRUPTCY COURT

FOR THE DISTRICT OF DELAWARE

 

- - - - - - - - - - - - - - - - - - - - - -  - - - - - - - - - - 

x
:
In re: : Chapter 11
:
DENDREON CORPORATION, et al., : Case No. 14-12515 (LSS)
:
          Debtors.1 : Jointly Administered
:
:
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  x

NOTICE OF FILING OF DEBTORS’ MONTHLY OPERATING REPORT

FOR THE PERIOD OF FEBRUARY 2015

PLEASE TAKE NOTICE that the above-captioned debtors and debtors in possession (collectively, the “Debtors”) have filed with the United States Bankruptcy Court for the District of Delaware the Debtors’ Monthly Operating Report for the Period of February 2015,

 

 

 

 

 

1 The Debtors and the last four digits of their respective taxpayer identification numbers are as follows: Dendreon Corporation (3193), Dendreon Holdings, LLC (8047), Dendreon Distribution, LLC (8598) and Dendreon Manufacturing, LLC (7123). The address of the Debtors’ corporate headquarters is 601 Union Street, Suite 4900, Seattle, Washington 98101.

 

Docket No. 513

Date Filed: 3/20/15


attached hereto as Exhibit A (the “Monthly Operating Report”).

 

Dated: Wilmington, Delaware
March 20, 2015

 

SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP

/s/ Sarah E. Pierce

Anthony W. Clark (I.D. No. 2051)
Sarah E. Pierce (I.D. No. 4648)
One Rodney Square
P.O. Box 636
Wilmington, Delaware 19899-0636
Telephone: (302) 651-3000
Fax: (302) 651-3001
- and -
Kenneth S. Ziman
Raquelle L. Kaye
Four Times Square
New York, New York 10036-6522
Telephone: (212) 735-3000
Fax: (212) 735-2000
- and -
Felicia Gerber Perlman
155 N. Wacker Drive
Chicago, Illinois 60606-1720
Telephone: (312) 407-0700
Fax: (312) 407-0411
Counsel for Debtors and Debtors in Possession

 

2


EXHIBIT A

MONTHLY OPERATING REPORT


UNITED STATES BANKRUPTCY COURT

                     DISTRICT OF DELAWARE                    

 

In re     DENDREON CORPORATION, et. al                                   Case No.     14-12515  (LSS)                      
  Reporting Period:    February 2015                      

MONTHLY OPERATING REPORT

File with Court and submit copy to United States Trustee within 20 days after end of month.

Submit copy of report to any official committee appointed in the case.

 

REQUIRED DOCUMENTS    Form No.      Document    
  Attached    
     Explanation  
  Attached  
   Affidavit/Supplement 
Attached 

Schedule of Cash Receipts and Disbursements

   MOR-1    X          

     Bank Reconciliation (or copies of debtor’s bank reconciliations)

   MOR-1a    X          

     Schedule of Professional Fees Paid

   MOR-1b         X     

     Copies of bank statements

             X     

     Cash disbursements journals

             X     

Statement of Operations

   MOR-2    X          

Balance Sheet

   MOR-3    X          

Status of Postpetition Taxes

   MOR-4         X     

    Copies of IRS Form 6123 or payment receipt

                   

    Copies of tax returns filed during reporting period

                   

Summary of Unpaid Postpetition Debts

   MOR-5    X          

    Listing of aged accounts payable

   MOR-5    X          

Accounts Receivable Reconciliation and Aging

   MOR-6         X     

Debtor Questionnaire

   MOR-7    X          

 

I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the attached documents are true and correct to the best of my knowledge and belief.   

 

 

    

 

     
Signature of Debtor       Date      

 

    

 

     
Signature of Joint Debtor       Date      

/s/ Gregory R. Cox

    

 March 20, 2015

  
Signature of Authorized Individual*           

    Gregory R. Cox

    

 Chief Financial Officer

  
Printed Name of Authorized Individual       Title of Authorized Individual      

 

*Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor is a partnership; a manager or member if debtor is a limited liability company.  


 

 NOTES

 

 Notes to the MOR:

This Monthly Operating Report (“MOR”) has been prepared solely for the purpose of complying with the monthly reporting requirements applicable in the Bankruptcy Case and is in a format acceptable to the U.S. Trustee. The financial information contained herein is limited in scope and covers a limited time period. Moreover, such information is preliminary and unaudited, and is not prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States. Accordingly, this MOR should not be used for investment purposes.

 

The financial statements presented in MOR-2 and MOR-3 are prepared on a consolidated company basis for the Debtors and non-debtor affiliates.

 

Page 2 of 13


 

 1. SCHEDULE OF CASH RECEIPTS AND DISBURSEMENTS

 ($ 000s)

 

             
 For the period 2/1/15 - 2/28/151        

 

 

 

Dendreon

 

  

      Dendreon          Dendreon          Dendreon     
       Consolidated                  Corporation                  Holdings                   Distribution                Manufacturing       
 

 Beginning Cash Balance2

  $ 118,660                    $ 118,660          $ -          $ -          $ -       
 

 Total Cash Receipts

    470,063            451,288          -          18,775          -     
 

 Total Cash Disbursements3

    (128,057         (122,233       -          (5,824       -     
 

 Intercompany Transfer From / (To) Other Debtors

    -            12,731          -          (12,731       -     
 

 Intercompany Transfer From / (To) Non-Debtors

    -            -          -          -          -     
 
 

 

 

       

 

 

     

 

 

     

 

 

     

 

 

   

 

 Net Cash Flow

$ 342,006    $ 341,786    $ -    $ 221    $ -   
 
 

 

 

       

 

 

     

 

 

     

 

 

     

 

 

   

 

 Ending Cash Balance2

 

$

 

460,666

 

  

 

$

 

460,446

 

  

 

$

 

-

 

  

 

$

 

221

 

  

 

$

 

-

 

  

 

 Notes:

 

 1. 2/28/15 represents last day of Debtors’ February weekly cash forecast

 2. Excludes restricted cash accounts

 3. Cash Disbursements include payroll that was disbursed by Dendreon Corporation through its centralized cash management system for the benefit of subsidiary debtors.

 Accordingly, disbursement amounts (for the purposes of calculating US Trustee fees) are as follows:

 

Debtor

 

Amounts

 

   

 

Dendreon Corporation

$ 114,679   

 

Dendreon Holdings

  -       

 

Dendreon Distribution

  6,599   

 

Dendreon Manufacturing

  6,779   

 

$

 

                128,057

 

  

 

Page 3 of 13


 

 1a. BANK RECONCILIATION (OR COPIES OF DEBTORS’ BANK RECONCILIATIONS)

 As of 2/28/15

                                                      Restricted Cash Accounts    
              Morgan Stanle          
 Bank         U.S. Ban         U.S. Ban         Smith Barne         U.S. Bank 1            U.S. Bank   

 

 Description

                  Operating Accoun                   Receipts Accoun                   Investment Accoun                       Payroll Accoun                   Escrow Account   

 Bank Balance

    $ 9,626,348        $ 6,044,458        $ 450,867,595        $ 249,425          $ 214,617   

 (+) Deposits in Transit

      419,788          -          -          -            -   

 (-) Outstanding Checks

      (792,427       -          -          (139,758         -   

 Other

      -          (5,823,646       -          -            -   
   

 

 

     

 

 

     

 

 

     

 

 

       

 

 

 

 

 Book Balance

$ 9,253,709    $ 220,812    $ 450,867,595    $ 109,667    $ 214,617   

 Notes:

 

 1. Account opened during postpetition period

 

Page 4 of 13


 

 1b. SCHEDULE OF PROFESSIONAL FEES PAID

 For the period 2/1/15 - 2/28/15

 

Firm             Payment Date             Amount                                                   

 

SULLIVAN & CROMWELL, LLP

      2/20/15          428,454.42      

 

PRIME CLERK LLC

    2/20/15        679.20      

 

DELOITTE FINANCIAL ADVISORY SERVICES LLP

    2/20/15        181,109.45      

 

SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP

    2/20/15        1,468,006.03      

 

LAZARD FRERES & CO. LLC

    2/20/15        204,000.00      

 

YOUNG CONAWAY STARGATT & TAYLOR, LLP

    2/20/15        161,863.37      

 

ALIXPARTNERS, LLP

    2/20/15        559,661.74      
     

 

Total

        $           3,003,774.21      

 

Page 5 of 13


 

 1c. COPIES OF BANK STATEMENTS

 The Debtors’ bank statements are voluminous and not included herein, but copies will be provided upon request

 

Page 6 of 13


 

1d. CASH DISBURSEMENTS JOURNALS

The Debtors’ cash disbursement journals are voluminous and not included herein, but copies will be provided upon request

 

Page 7 of 13


 

 2. STATEMENT OF OPERATIONS

 ($ 000s)

 

 For the period 2/1/15 - 2/28/15

 

 

 

Dendreon

 

  

  Dendreon      Dendreon      Dendreon   
       Consolidated 1                  Corporation                    Holdings                     Distribution                 Manufacturing      
 

 Product Revenue, net

$ 13,842    $ 13,842    $ -    $ -    $ -   

 

 Royalty and Other Revenue

  -            -      -      -      -   
   

 

 

         

 

 

       

 

 

       

 

 

       

 

 

 

 

 Total Revenue

$ 13,842    $ 13,842    $ -    $ -    $ -   
 

 Operating Expenses:

 

 Cost Of Product Revenue

  7,845      7,845      -      -      -   

 

 Research and Development

  4,083      4,083      -      -      -   

 

 Selling, General and Administrative

  22,931      22,931      -      -      -   

 

 Less: Payroll Expense Included In Categories Above2

    (18,125     (18,125       -          -          -   

 

 Payroll Expense2,3

  18,125      4,747      -      6,599      6,779   

 

 Restructuring

  1,891      1,891      -      -      -   
   

 

 

         

 

 

       

 

 

       

 

 

       

 

 

 

 

 Total Operating Expenses

$ 36,750    $ 23,372    $ -    $ 6,599    $ 6,779   
 
   

 

 

         

 

 

       

 

 

       

 

 

       

 

 

 

 

 Income / (Loss) from Operations

$ (22,907 $ (9,530 $ -    $ (6,599 $ (6,779
 

 Other Income / (Expense):

 

 Interest Income

 

  (21   (21   -      -      -   

 Interest Expense

  (229   (229   -      -      -   

 

 Other Income / (Expense)

  253,629      253,629      -      -      -   

 

 Reorganization Expense

  (7,999   (7,999   -      -      -   
   

 

 

         

 

 

       

 

 

       

 

 

       

 

 

 

 

 Net Income / (Loss)

 

$ 222,473    $ 235,850    $ -    $ (6,599 $ (6,779

 Notes:

 

1. The Debtors maintain their accounting records and prepare financial statements on a consolidated basis only. This modified presentation reflects cash basis payroll of the subsidiary entities, which is funded by Dendreon Corp.

 

2. The Debtors’ consolidated statement of operations reflects an allocation of payroll expenses among several operating expense categories (i.e., Cost of Product Revenue, R&D and SG&A). For the purpose of presenting payroll by entity without double-counting of such expenses, the cash basis payroll must be deducted before being included separately

 

3. Payroll Expense (noted above) includes payroll, payroll taxes and 401(k). These amounts are funded to ADP via the US Bank Operating account. For taxation purposes, each legal entity pays separate state employment taxes for the states in which it operates

 

Page 8 of 13


 

 3. BALANCE SHEET

 

  

 ($ 000s)

  

 As of 2/28/15

  
    

  Consolidated1  

 

 

 Current Assets:

  

 

 Cash and Cash Equivalents

 

    $

 

460,666

 

  

 

 Short-Term Investments

 

    

 

-

 

  

 

 Trade Accounts Receivable

 

    

 

-

 

  

 

 Inventory

 

    

 

-

 

  

 

 Prepaid Expenses and Other Current Assets

 

    

 

618

 

  

 

  

 

 

 

 Total Current Assets

    $ 461,284   

 Property and Equipment, net

 

    

 

-

 

  

 

 Long-Term Investments

 

    

 

49,500

 

  

 

 Other Assets

 

    

 

2,623

 

  

 

  

 

 

 

 Total Assets

    $ 513,406   

 Current Liabilities:

  

 

 Accounts Payable

 

 

    $ 1,205   

 Accrued Liabilities

 

     329   

 Accrued Compensation

 

     3,006   

 Restructuring Liability

 

     -   

 Reorganization Liability

 

     5,393   

 Current Portion of Capital Lease Obligations

 

     -   

 Current Portion of Facility Lease Obligations

 

    

 

-

 

  

 

  

 

 

 

 Total Current Liabilities

    $ 9,932   

 Long-Term Liabilities:

  

 

 Other Long-Term Liabilities

 

  

 

 

 

 

-

 

 

  

 

 Liabilities Subject to Compromise2

 

    

 

595,629

 

  

 

  

 

 

 

Total Liabilities

    $ 605,561   

 Stockholders’ Equity:

  

 

 Common Stock

    

 

156

 

  

 

 

 Additional Paid-In Capital

    

 

2,021,921

 

  

 

 

 Accumulated Other Comprehensive Income

    

 

-

 

  

 

 

 Accumulated Deficit

 

    

 

(2,114,232

 

 

  

 

 

 

 Total Stockholders’ Equity (Deficit)

 

 

    $

 

(92,155

 

 

  

 

 

 

 Total Liabilities and Stockholders’ Equity

    $ 513,406   
 Notes:   

1. The Debtors maintain their accounting records and prepare financial statements on a consolidated basis only

 

2. The Debtors continue to work to determine the proper balance and reporting for Liabilities Subject to Compromise

   

   

 

Page 9 of 13


 

 4. STATUS OF POSTPETITION TAXES

 

 All postpetition taxes were current as of 1/31/15 and paid in the ordinary course by the Debtors

 

Page 10 of 13


 

 5. SUMMARY OF UNPAID POSTPETITION DEBTS

 

 As of 2/28/15

      Days Outstanding  
  Total  

 

1 - 30

  31 - 60   61 - 90   91 +  

 Postpetition Accounts Payable

  $         1,204,512        $         1,204,512        $                     -        $                     -        $                     -     

 

Page 11 of 13


 

 6. ACCOUNTS RECEIVABLE RECONCILLIATION & AGEING

 

 Pursuant to the sale, accounts receivable are no longer property of the Debtors’ estate

 

Page 12 of 13


 

 7. DEBTOR QUESTIONNAIRE

 

 

       

            Yes            

 

            No            

1.

  Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below   X  
           

2.

  Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below     X
           

3.

  Have all postpetition tax returns been timely filed? If no, provide an explanation below   X  
           

4.

  Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below   X  
           

5.

  Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3     X

 

Note 1:  

On February 23, 2015, the Debtors completed the sale of substantially all the Debtor’s assets to a subsidiary of Valeant Pharmaceuticals, Inc. pursuant to the terms sale agreement approved by the court on February 20, 2015.

 

Page 13 of 13